πŸ‡ΊπŸ‡Έ FDA
Patent

US 11311541

Treatment of GVHD

granted A61KA61K31/506A61K31/517

Quick answer

US patent 11311541 (Treatment of GVHD) held by Regents of the University of Minnesota expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/506, A61K31/517, A61K31/519, A61K31/53